Thyroid Cancer in Patients with Hyperthyroidism

 

 Permissions and Reprints

Abstract

Thyroid cancer can be associated with thyrotoxicosis caused by Graves’ disease, toxic multinodular goiter, or autonomously functioning thyroid adenoma. The objective of this study was to summarize current evidence regarding the association of thyroid cancer and hyperthyroidism, particularly with respect to the type of hyperthyroidism found in some patients, and whether this affects the outcome of the patient. A PubMed search was performed up to August 2011. Articles were identified using combinations of the following keywords/phrases: thyroid cancer, papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, anaplastic thyroid cancer, hyperthyroidism, Graves’ disease, auto­nomous adenoma, toxic thyroid nodule, and toxic multinodular goiter. Original research papers, case reports, and review articles were included. We concluded that the incidence, as well as the prognosis of thyroid cancer associated with hyperthyroidism is a matter of debate. It seems that Graves’ disease is associated with larger, multifocal, and potentially more aggressive thyroid cancer than single hot nodules or multinodular toxic goiter. Patients with Graves’ and thyroid nodules are at higher risk to develop thyroid cancer compared to patients with diffuse goiter. Every suspicious nodule associated with hyperthyroidism should be evaluated carefully.

• References

• 1 Means JH. The thyroid and its diseases. Philadelphia: JB Lippincott Co; 1937: 482
  Google Scholar
• 2 Sokal JE. Incidence of malignancy in toxic and non-toxic nodular goiter. JAMA 1954; 154: 1321-1325
  CrossrefPubMedGoogle Scholar
• 3 Beahrs OH, Pemberton J, Black BM. Nodular goiter and malignant lesion of the thyroid gland. J Clin Endocrinol 1951; 11: 1157-1165
  CrossrefPubMedGoogle Scholar
• 4 Olen E, Klinck GH. Hyperthyroidism and thyroid cancer. Arch Pathol 1966; 81: 531-535
  PubMedGoogle Scholar
• 5 Shapiro SJ, Friedmam NB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves’ disease. Cancer 1970; 26: 1261-1270
  CrossrefPubMedGoogle Scholar
• 6 Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006; 295: 2164-2167
  CrossrefPubMedGoogle Scholar
• 7 Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 2009; 18: 784-791
  CrossrefPubMedGoogle Scholar
• 8 Cappelli C, Braga M, Martino ED, Castellano M, Gandossi E, Agosti B, Cumetti D, Pirola I, Mattanza C, Cherubini L, Rosei EA. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: Experience at an Endocrine Center in Italy. Surg Today 2006; 36: 125-130
  CrossrefPubMedGoogle Scholar
• 9 Mazzaferri EL. Thyroid cancer and Graves’s disease. J Clin Endocrinol Metab 1990; 70: 826-829
  CrossrefPubMedGoogle Scholar
• 10 Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves’ disease. World J Surg 1990; 14: 437-441
  CrossrefPubMedGoogle Scholar
• 11 Pazaitou-Panayiotou K, Perros P, Boudina M, Drimonitis A, Siardos G, Patakiouta F, Vainas I. Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience. Eur Journal Endocrinol 2008; 159: 799-803
  PubMedGoogle Scholar
• 12 Hayes FJ, Sheaham K, Heffernan A, McKenna TJ. Aggressive thyroid cancer associated with toxic nodular goitre. Eur J Endocrinol 1996; 134: 366-370
  CrossrefPubMedGoogle Scholar
• 13 Hales IB, McElduff Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve TS, Wilmshurst E, Wiseman J. Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 1992; 75: 886-889
  CrossrefPubMedGoogle Scholar
• 14 Pacini F, DiCoscio GC, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A. Thyroid carcinoma in thyrotoxicosis patients treated by surgery. J Endocrinol Invest 1988; 11: 107-112
  PubMedGoogle Scholar
• 15 Taneri F, Kurukahvecioglu O, Ege B, Yilmaz U, Tekin EH, Cifter C, Onuk E. Clinical presentation and treatment of hyperthyroidism associated with thyroid cancer. Endocr Regul 2005; 39: 91-96
  PubMedGoogle Scholar
• 16 Sahin M, Guvener ND, Ozer F, Sengul A, Ertugrul D, Tutuncu NB. Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group. J Endocrinol Invest 2005; 28: 815-818
  PubMedGoogle Scholar
• 17 Senyurek Giles Y, Tunka F, Boztepe H, Kapran Y, Terzioglu T, Tezelman S. The risk factors for malignancy in surgically treated patients for Graves’ disease, toxic multinodular goiter, and toxic adenoma. Surgery 2008; 144: 1028-1037
  CrossrefPubMedGoogle Scholar
• 18 Cakir M, Arici C, Alakus H, Altunbas H, Balci MK, Karayalcin U. Incidental thyroid carcinoma in thyrotoxic patients treated by surgery. Horm Res 2007; 67: 96-99
  PubMedGoogle Scholar
• 19 Terzioglou T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg 1993; 80: 1301-1302
  CrossrefPubMedGoogle Scholar
• 20 Linos DA, Karakitsos D, Papademetriou J. Should the primary treatment of hyperthyroidism be surgical?. Eur J Surg 1997; 163: 651-657
  PubMedGoogle Scholar
• 21 Vaiana R, Cappelli C, Perini P, Pinelli D, Camoni G, Farfaglia R, Balzano R, Braga M. Hyperthyroidism and concurrent thyroid cancer. Tumori 1999; 85: 247-252
  PubMedGoogle Scholar
• 22 Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, Izzo L, Cavallaro A. Thyroid cancer in patients with hyperthyroidism. Horm Res 2003; 60: 79-83
  CrossrefPubMedGoogle Scholar
• 23 Miccoli P, Minuto MN, Galleri D, D’Agostino J, Basolo F, Antonangeli L, Aghini-Lombardi F, Berti P. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg 2006; 76: 123-126
  CrossrefPubMedGoogle Scholar
• 24 Lin CH, Chiang FY, Wang LF. Prevalence of thyroid cancer in hyperthyroidism treated by surgery. Kaohsiung J Med Sci 2003; 19: 379-384
  CrossrefPubMedGoogle Scholar
• 25 Zanella E, Rulli F, Muzi M, Sianesi M, Danese D, Sciacchitano S, Pontecorvi A. Prevalence of thyroid cancer in hyperthyroid patients treated by surgery. World J Surg 1998; 22: 473-478
  CrossrefPubMedGoogle Scholar
• 26 Calò PG, Tatti A, Farris S, Malloci A, Nicolosi A. Differentiated thyroid carcinoma and hyperthyroidism: a frequent association?. Chir Ital 2005; 57: 193-197
  PubMedGoogle Scholar
• 27 Fukunaga FH, Lockett LJ. Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol 1971; 92: 6-13
  PubMedGoogle Scholar
• 28 Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975; 36: 1095-1099
  CrossrefPubMedGoogle Scholar
• 29 Habra MA, Hijazi R, Verstovsek G, Marcell M. Medullary thyroid carcinoma associated with hyperthyroidism: a case report and review of the literature. Thyroid 2004; 14: 391-396
  CrossrefPubMedGoogle Scholar
• 30 Alagöl F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F. Anaplastic thyroid cancer with transiet thyrotoxicosis: case report and literature review. Thyroid 1999; 9: 1029-1032
  CrossrefPubMedGoogle Scholar
• 31 Belfiore A, Garofalo MR, Giuffrida D, Runello F, Filetti S, Fiumara A, Ippolito O, Vigneri R. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinol Metab 1990; 70: 830-835
  CrossrefPubMedGoogle Scholar
• 32 Pellegriti G, Belfiore A, Giuffrida D, Lupo L Vigneri Outcome of Differentiated Thyroid Cancer in Graves’ Patients. J Clin Endocrinol Metab 1998; 83: 2805-2809
  CrossrefPubMedGoogle Scholar
• 33 Yeo PP, Wang KW, Sinniah R, Aw TC, Chang CH, Sethi VK, Tan BC, Lim P. Thyrotoxicosis and thyroid cancer. Aust N Z J Med 1982; 12: 598-593
  CrossrefPubMedGoogle Scholar
• 34 Farbota LM, Calandra DB, Lawrence AM, Paloyan R. Thyroid carcinoma in Graves’ disease. Surgery 1985; 98: 1145-1152
  PubMedGoogle Scholar
• 35 Lee J, Nam KH, Chung WY, Soh EY, Park CS. Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves’ disease. J Korean Med Sci 2008; 23: 796-801
  CrossrefPubMedGoogle Scholar
• 36 Foppiani L, Del Monte P, Marugo A, Arlandini A, Sartini G, Marugo M, Bernasconi D. Heterogeneous malignancy in toxic thyroid nodule, letter to the Editor. J Endocrinol Invest 2005; 28: 294-295
  PubMedGoogle Scholar
• 37 Gerenova J, Buysschaert M, de Burbure CY, Daumerie C. Prevalence of thyroid cancer in Graves’s disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med 2003; 14: 321-325
  CrossrefPubMedGoogle Scholar
• 38 Erbil Y, Barbaros U, Ozbey N, Kapran Y, Tükenmez M, Bozbora A, Ozarmağan S. Graves’ disease, with and without nodules, and the risk of thyroid carcinoma. J Laryngl Otol 2008; 122: 291-295
  PubMedGoogle Scholar
• 39 Kraimps JL, Bouin-Pincau MH, Mathonnet M, De Calan L, Ronceray J, Visset J, Marechaud R, Barbier J. Multicentre study of thyroid nodules in patients with Graves’ disease. Br J Surg 2000; 87: 1111-1113
  CrossrefPubMedGoogle Scholar
• 40 Behar R, Arganini M, Wu TC, McCormick M, Straus FH, DeGroot LJ, Kaplan EL. Graves’ disease and thyroid cancer. Surgery 1986; 100: 1121-1127
  PubMedGoogle Scholar
• 41 Ain KB. Papillary thyroid carcinoma – etiology, assessment and therapy. Endocrinol Metab Clin North Am 1995; 24: 711-760
  PubMedGoogle Scholar
• 42 Kikuchi S, Noguchi S, Yamashita H, Uchino S, Kawamoto H. Prognosis of small thyroid cancer in patients with Graves’ disease. Br J Surg 2006; 93: 434-439
  CrossrefPubMedGoogle Scholar
• 43 Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves’ disease. Minerva Endocrinol 2003; 28: 205-212
  PubMedGoogle Scholar
• 44 Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK. Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease. Clin Endocrinol (Oxf) 2004; 60: 719-725
  CrossrefPubMedGoogle Scholar
• 45 Edmonds CJ, Tellez M. Hyperthyroidism and thyroid cancer. Clin Endocrinol (Oxf) 1998; 28: 253-259
  PubMedGoogle Scholar
• 46 Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, Ito K. Recent outcome of Graves’ disease patients with papillary thyroid cancer. Eur J Endocrinol 2007; 157: 325-329
  CrossrefPubMedGoogle Scholar
• 47 Duh QY. Thyroid cancer in Graves’ disease: incidental cancer versus clinical cancer. Ann Surg Oncol 2004; 11: 356-357
  CrossrefPubMedGoogle Scholar
• 48 Phitayakorn R, McHenry CR. Incidental thyroid carcinoma in patients with Graves’ disease. Am J Surg 2008; 195: 292-297
  CrossrefPubMedGoogle Scholar
• 49 Chao TC, Lin JD, Chen MF. Surgical treatment of thyroid cancers with concurrent Graves disease. Ann Surg Oncol 2004; 11: 407-412
  CrossrefPubMedGoogle Scholar
• 50 Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules. Relevance of iodine intake, sex, age and multinodularity. Am J Med 1992; 93: 363-369
  CrossrefPubMedGoogle Scholar
• 51 Welker MJ, Orlov D. Thyroid Nodules. Am Fam Phycisian 2003; 67: 3
  PubMedGoogle Scholar
• 52 Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93: 359-362
  CrossrefPubMedGoogle Scholar
• 53 Belfiore A, Russo D, Vigneri R, Filetti S. Graves’ disease, thyroid nodules and thyroid cancer. Clin Endocrinol 2001; 55: 711-718
  CrossrefPubMedGoogle Scholar
• 54 Stocker DJ, Foster SS, Solomon BL, Shriver CD, Burch HB. Thyroid cancer yield in patients with Graves’ disease selected for surgery on the basis of cold scintiscan defects. Thyroid 2002; 12: 305-311
  CrossrefPubMedGoogle Scholar
• 55 Gharib H, Papini E, Paschke R, Duick DS, Valcalvi R, Hegedüs L, Vitti P. AACE/AME/ETA Task Force on Thyroid Nodules 2010 . American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules executive summary and recommendations. J Endocrinol Invest 2010; 33: 287-291; Hot Thyroidology 4: 1–88; Endocr Pract 16 (Suppl 1): 1–43
  PubMedGoogle Scholar
• 56 Centeno BA, Szyfelbein WM, Daniels GH, Vickery Jr AL. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves’ disease treated with radioactive iodine. Morphologic findings and potential pitfalls. Acta Cytol 1996; 40: 1189-1197
  CrossrefPubMedGoogle Scholar
• 57 Anderson SR, Mandel S, LiVolsi VA, Gupta PK, Baloch ZW. Can cytomorphology differentiate between benign nodules and tumors arising in Graves’ disease?. Diagn Cytopathol 2004; 31: 64-67
  CrossrefPubMedGoogle Scholar
• 58 Ozaki O, Ito K, Mimura T, Sugino K, Kitamura Y, Iwabuchi H, Kawano M. Thyroid carcinoma after radioactive iodine therapy for Graves’ disease. World J Surg 1994; 18: 518-521
  CrossrefPubMedGoogle Scholar
• 59 Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988; 9: 106-121
  CrossrefPubMedGoogle Scholar
• 60 Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R, Ingbar SH. The role of thyroid-stimulating antibodies of Graves’ disease in differentiated thyroid cancer. N Engl J Med 1988; 318: 753-759
  CrossrefPubMedGoogle Scholar
• 61 Morshed SA, Latif R, Davies TF. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 2009; 150: 519-529
  Google Scholar
• 62 Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid: a long-term follow-up of 867 patients. Arch Surg 1996; 131: 187-191
  CrossrefPubMedGoogle Scholar
• 63 Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. and the European Thyroid cancer Taskforce . European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803
  CrossrefPubMedGoogle Scholar
• 64 Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Sherman SI, Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-142
  CrossrefPubMedGoogle Scholar
• 65 Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167-1214
  Google Scholar
• 66 Stålberg P, Svensson A, Hessman O, Akerström G, Hellman P. Surgical treatment of Graves’ disease: evidence-based approach. World J Surg 2008; 32: 1269-1277
  CrossrefPubMedGoogle Scholar
• 67 Ikekubo K, Hino M, Ito H, Otami M, Yamaguchi H, Saiki Y, Ui K, Habuchi Y, Ishihsra T, Mori T. Thyroid carcinoma in solitary hot thyroid lesions on Tc-99m sodium pertechnetat scans. Ann Nucl 1989; Med 3: 31-36
  PubMedGoogle Scholar
• 68 Uludag M, Yetkin G, Citgez B, Isgor A, Basak T. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones (Athens) 2008; 7: 175-179
  PubMedGoogle Scholar
• 69 Cirillo Jr RL, Pozderac RV, Caniano DA, Falko JM. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med 1998; 23: 345-349
  CrossrefPubMedGoogle Scholar
• 70 Majima T, Doi K, Komatsu Y, Itoh H, Fukao A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R, Nakao K. Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. Endocr J 2005; 52: 309-316
  CrossrefPubMedGoogle Scholar
• 71 Low SC, Sinha AK, Sundram FX. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. Singapore Med J 2005; 46: 304-307
  PubMedGoogle Scholar
• 72 Ahuja S, Ernst H. Hyperthyroidism and thyroid carcinoma. Acta Endocrinol (Copenh) 1991; 124: 146-151
  PubMedGoogle Scholar
• 73 Mizukami Y, Michigishi T, Nonomura A, Yokoyama K, Noguchi M, Hashimoto T, Nakamura S, Ishizaki T. Autonomously functioning (hot) nodule of the thyroid gland. A clinical and histopathologic study of 17 cases. Am J Clin Pathol 1994; 101: 29-35
  PubMedGoogle Scholar
• 74 Hamburger JI. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med 1975; 58: 740-748
  CrossrefPubMedGoogle Scholar
• 75 Goretzki P, Wahl RA, Branscheid D, Joseph K, Tsuchiya A, Roher HD. Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas. World J Surg 1985; 9: 149-155
  CrossrefPubMedGoogle Scholar
• 76 Harach HR, Sanchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol 2002; 6: 10-19
  CrossrefPubMedGoogle Scholar
• 77 Smith M, McHenry C, Jarosz H, Lawrence AM, Paloyan E. Carcinoma of the thyroid in patients with autonomous nodules. Am Surg 1988; 54: 488-489
  PubMedGoogle Scholar
• 78 Schröder S, Marthaler B. Autonomy and malignancy of thyroid glad tumors. A critical analysis of the literature on the existence of hyperfunctioning follicular and papillary thyroid gland carcinomas. Pathologe 1996; 17: 349-357
  CrossrefPubMedGoogle Scholar
• 79 Daumerie C, Ayoubi S, Rahier J, Buysschaert M, Squifflet JP. Prevalence of thyroid cancer in hot nodules. Ann Chir 1998; 52: 444-448
  PubMedGoogle Scholar
• 80 Croom 3rd RD, Thomas Jr CG, Reddick RL, Tawil MT. Autonomously functioning thyroid nodules in childhood and adolescence. Surgery 1987; 102: 1101-1108
  PubMedGoogle Scholar
• 81 Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. J Paediatr Endocrinol Metab 2002; 15: 823-830
  PubMedGoogle Scholar
• 82 Als C, Gedeon P, Rosler H, Minder C, Netzer P, Laissue JA. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab 2002; 87: 4122-4127
  CrossrefPubMedGoogle Scholar
• 83 Niepomniszcze H, Suarez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, Elsner B, Bruno OD. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620l) and a mutation of Ki-RAS (G12C) genes. Thyroid 2006; 16: 497-503
  CrossrefPubMedGoogle Scholar
• 84 Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G, Fagin JA. Structural studies of the thyrotropin receptor and GSα in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab 1996; 81: 3898-3901
  CrossrefPubMedGoogle Scholar
• 85 Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S, Belfiore A. Detection of an activation mutation of the thyrotropin receptor in a case of autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 1997; 82: 735-738
  CrossrefPubMedGoogle Scholar
• 86 Russo D, Wong MG, Costance G, Chiefari E, Treseler PA, Arturi F, Filetti S, Clark OH. A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid 1999; 9: 13-17
  CrossrefPubMedGoogle Scholar
• 87 Camacho P, Gordon D, Chiefari E, Yong S, Dejong S, Pitale S, Russo D, Filetti S. A Phe 486 Thyrotropin receptor mutation in an autonomously functioning folliculer carcinoma that was causing hyperthyroidism. Thyroid 2000; 10: 1009-1012
  CrossrefPubMedGoogle Scholar
• 88 Mircescu H, Parma J, Huot C, Deal C, Oligny LL, Vassart G, Van Vliet G. Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J Pediatr 2000; 137: 585-587
  CrossrefPubMedGoogle Scholar
• 89 Fuhrer D, Tannapfel A, Sabri O, Lamesch P, Paschke R. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer 2003; 10: 591-600
  CrossrefPubMedGoogle Scholar
• 90 Gozu H, Avsar M, Bircan R, Sahin S, Ahiskanali R, Gulluoglu B, Deyneli O, Ones T, Narin Y, Akalin S, Cirakoglu B. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?. Thyroid 2004; 14: 975-980
  CrossrefPubMedGoogle Scholar
• 91 Jaeschke H, Mueller S, Eszlinger M, Paschke R. Lack of in vitro constitutive activity for three previously reported TSH receptor mutations identified in patients with non autoimmune hyperthyroidism and hot thyroid carcinomas. Clin Endocrinol (Oxf) 2010; 73: 815-820
  CrossrefPubMedGoogle Scholar
• 92 Cerci C, Cerci SS, Eroglu E, Dede M, Kapucuoglu N, Yildiz M, Bulbul M. Thyroid cancer in toxic and non-toxic multinodular goiter. J Postgrad Med 2007; 53: 157-160
  CrossrefPubMedGoogle Scholar
• 93 Chigot JP, Ménégaux F, Keopadabsy K, Hoang C, Aurengo A, Leenhardt L, Turpin G. Thyroid cancer in patients with hyperthyroidism. Presse Med 2000; 29: 1969-1972
  PubMedGoogle Scholar
• 94 Lian X, Bai Y, Tang W, Dai W, Guo Z. A clinical study on coincidence with hyperthyroidism and thyroid carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2000; 22: 273-275
  PubMedGoogle Scholar
• 95 Ruggieri M, Scocchera F, Genderini M, Mascaro A, Luongo B, Paolini A. Hyperthyroidism and concurrent thyroid carcinoma. Eur Rev Med Pharmacol Sci 1999; 3: 265-268
  PubMedGoogle Scholar
• 96 Omür O, Yazc B, Akgün A, Ozcan Z, Akyldz M, Argon M, Ozklç H. Concomitant hyperthyroidism in patients with thyroid carcinoma and the effects of iodine supplementation in an iodine-deficient Area. Clin Nucl Med 2008; 33: 769-772
  CrossrefPubMedGoogle Scholar
• 97 Kilpatrick R, Blomfield GW, Neal FE, Wilson GM. Carcinoma of the thyroid. J Med 1957; 26: 209-233
  PubMedGoogle Scholar
• 98 Hancock BW, Bing RF, Dirmikis SM, Munro DS, Neal FE. Thyroid carcinoma and concurrent hyperthyroidism. Cancer 1997; 39: 298-302
  PubMedGoogle Scholar
• 99 Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine (Baltimore) 1977; 56: 171-196
  PubMedGoogle Scholar
• 100 Hall R, Ross M, Teng CS, Smith BR. Immunological aspects of thyroid cancer. Recent Results Cancer Res 1980; 73: 56-59
  PubMedGoogle Scholar
• 101 Wahl RA, Goretzki P, Meybier H, Nitschke J, Linder M, Roher HD. Coexistence of hyperthyroidism and thyroid cancer. World J Surg 1982; 6: 385-390
  CrossrefPubMedGoogle Scholar
• 102 Vini L, Hyer S, Pratt B, Harmer C. Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. Postgrad Med J 1999; 75: 169-170
  PubMedGoogle Scholar
• 103 Bolko P, Lacka K, Manuszewska E, Ruchala M, Majewski P, Sowinski J. Is hyperthyroidism often present in patients with thyroid differentiated carcinoma?. Pol Arch Med Weun 2002; 107: 555-559
  PubMedGoogle Scholar
• 104 Gulcelik MA, Gulcelik NE, Dinc S, Kuru B, Camlibel M, Alagol H. The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. J Surg Oncol 2006; 94: 35-39
  CrossrefPubMedGoogle Scholar
• 105 Zhu XG, Cheng SY. Modeling thyroid cancer in the mouse. Horm Metab Res 2009; 41: 488-499
  Article in Thieme ConnectPubMedGoogle Scholar
• 106 Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN. Society of Radiologists in Ultrasound . Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005; 237: 794-800
  CrossrefPubMedGoogle Scholar